Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
|ClinicalTrials.gov Identifier: NCT00007007|
Recruitment Status : Completed
First Posted : March 8, 2004
Last Update Posted : March 27, 2015
RATIONALE: Assessment of patients undergoing radiation therapy may help to determine the effects of the treatment and may help improve cancer treatment.
PURPOSE: This clinical trial is studying the memory skills in patients receiving radiation therapy for brain metastases.
|Condition or disease||Intervention/treatment|
|Cognitive/Functional Effects Metastatic Cancer Radiation Toxicity||Procedure: management of therapy complications Procedure: quality-of-life assessment|
OBJECTIVES: I. Determine the feasibility of performing a test battery consisting of five neurocognitive measures and a quality of life instrument following radiotherapy in patients with brain metastases.
OUTLINE: Patients undergo radiotherapy 5 days a week for 3 weeks. Quality of life and neurocognitive function is assessed before study, at completion of radiotherapy, and at 1 month after completion of radiotherapy. Patients are followed at 1 month.
PROJECTED ACCRUAL: A total of 50 patients will be accrued for this study over 5 months.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||59 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Feasibility Study of Neurocognitive Evaluation in Patients Treated for Brain Metastases|
|Study Start Date :||November 2000|
|Primary Completion Date :||December 2004|
|Study Completion Date :||December 2004|
Experimental: Whole brain radiation therapy + neurocognitive assessments
Whole brain radiation therapy (WBRT) with neurocognitive assessments done pre and post WBRT.
|Procedure: management of therapy complications Procedure: quality-of-life assessment|
- Feasibility of performing a test battery of neurocognitive and quality of life measures [ Time Frame: From registration to one month post radiation therapy ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00007007
Show 241 Study Locations
|Study Chair:||William F. Regine, MD||Lucille P. Markey Cancer Center at University of Kentucky|